Introduced last year, the AETOS Shoulder System delivers an elegant design and an elevated experience through its simplicity, ...
A live webcast of this presentation can be accessed by visiting “Investor Events” on the Investor Relations section of the Wave Life Sciences website: ...
BETHESDA, MD, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH” or the “Company”) (Nasdaq: HWH) is pleased to announce a strategic partnership with Asia Business College to launch its ...
Healthcare Integrated Technologies, Inc. Welcomes Tim Brady as its Full-Time Chief Financial Officer
Knoxville, Tennessee, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator in healthcare solutions, is proud to announce the December 1, 2024 ...
Akari Therapeutics, Plc (Nasdaq: AKTX) today announced the appointment of Torsten Hombeck, Ph.D. as Chief Financial Officer, ...
Oragenics, Inc. (NYSE: OGEN), a biotechnology company advancing innovative treatments for brain-related health conditions, today announced the conversion of its remaining outstanding convertible ...
New InsiGHTS randomized and dosed 49 children with Turner syndrome aged 1 to 10 years old into one of four treatment groups 1:1:1:1 – one of three starting doses of TransCon hGH (0.24, 0.30, or 0.36 ...
Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...
BioSyent has entered into an automatic share purchase plan with a broker, Raymond James Ltd., in connection with the NCIB to allow for the purchase of Shares during certain pre-determined blackout ...
ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba® is the subject of an exclusive, transferable license to Scilex ...
Members of the invIOs management team will be available for one-on-one meetings to showcase the Company’s dynamic immuno-oncology pipeline and discuss its corporate strategy and plans for 2025. The ...
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the completion of the first patient procedure for inclusion in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback